ZMIZ1, variants, traits, and what the research shows

ZMIZ1 - what this gene does

ZMIZ1 shows a consistent pattern across its on-file variants: every top-ranked variant points toward the rare disease trait category. Without trait-specific study summaries in the current data, the gene's connection to specific conditions cannot be characterized, but the breadth and uniformity of rare disease associations across the variant set is clear.

Key takeaways

• ZMIZ1 has 396 variants on file, with all 20 top-ranked variants linked to rare disease associations.
• Every top-ranked variant carries a magnitude score of 5.50, indicating consistent signal strength across this category.
• Specific condition names within the rare disease category are not yet detailed in the available data.
• These are population-level statistical signals, not predictions for any individual.
• Detailed study summaries are pending for these variants; treat current findings as preliminary.

Notable variants

The highest-priority variants include rs1039220588, rs1156561540, rs1196469674, rs1345500965, rs1380703248, rs1403477903, rs1589579500, and rs201282468. Each carries a magnitude of 5.50 and is classified under the rare disease trait category. The uniformity of this profile across so many distinct variants is a striking feature of the on-file data, though specific trait annotations are not yet available for any of them.

Trait associations

All 20 top-ranked variants - including rs1853909290, rs201734007, rs2132032720, rs2132032860, rs2492115085, rs2492126530, rs2492157159, rs2492205344, rs545179298, rs572323939, and rs746314274 - fall under the broad rare disease trait theme. The repetition of this classification across the full set of top-ranked variants strengthens the case that the gene is a consistent signal in rare disease genetics, though replication status and specific conditions cannot be confirmed from the current data.

Evidence quality

The top-ranked variants carry magnitude scores of 5.50, which indicates meaningful signal strength in a genome-wide context. However, no study-level details are present in the current data set, including sample sizes, cohort descriptions, or replication status. Without knowing whether these associations derive from large multi-cohort GWAS studies (genome-wide association studies - scans of many people's genomes for variants statistically linked to a trait) or smaller single-cohort analyses, a full assessment of evidence quality is not possible. The broad rare disease classification covers a wide range of conditions, and trait-specific annotations are not yet available for any of the 20 top-ranked variants, so all findings should be treated as preliminary.

What this is NOT

These variants represent population-level statistical signals observed across large groups of people and are not deterministic predictors of any outcome for any individual. This entry does not constitute medical advice, a diagnosis, or a recommendation of any kind.